A prospective multicenter registry on outcomes of endovascular treatment in patients with atherosclerotic femoropopliteal artery disease in Japan

A prospective multicenter registry on outcomes of endovascular treatment in patients with atherosclerotic femoropopliteal artery disease in Japan - Guide SFA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026968

Enrollment

3500

Registered

2017-04-12

Start date

2017-04-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with symptomatic PAD with lesions in femoropopliteal artery who have elected to receive endovascular treatment.

Interventions

None listed

Sponsors

Japan Endovascular Treatment Conference Office of Guide SFA Registry

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Informed consent to being a subject of this study and agreeing to undergo follow-up examinations at 30 days, and 1 and 2 years after receiving EVT.

Exclusion criteria

Exclusion criteria: 1) Planned bypass surgery or major amputation within 30 days after EVT, 2) Life expectancy of less than two years, 3) Acute limb ischemia (ALI), 4) Anti-thrombotic treatment is not applicable.

Design outcomes

Primary

Measure	Time frame
Freedom from Target Vessel Revascularization (TVR)in the index limb at 1 and 2 year(s)	—

Secondary

Measure	Time frame
Improvement of walking ability measured by means of WIQ or a medical interview, MAE within 30days after index procedure, EVT procedure related adverse events	—

Countries

Japan

Contacts

Public ContactKaori Shimogama

Japan Endovascular Treatment Conference Office of Guide SFA Registry

guide-sfa.registry@j-et.jp03-3468-1251

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026